Skip to main content
Top
Published in: Cancer Immunology, Immunotherapy 6/2020

01-06-2020 | Prostate Cancer | Letter to the Editors

ESTIMATE algorithm is not appropriate for inferring tumor purity and stromal and immune cell admixture in hematopoietic or stromal tumors

Authors: Qiang Liu, Yi Fang, Jing Wang

Published in: Cancer Immunology, Immunotherapy | Issue 6/2020

Login to get access

Excerpt

With great interest, we have read the recent article entitled “Identification of prognostic genes in the acute myeloid leukemia immune microenvironment based on TCGA data analysis” [1] (by Yan et al. Cancer Immunol Immunother (2019) 68: 1971), which tried to identify key microenvironment-related genes correlated with prognosis of acute myeloid leukemia by analyzing publicly available gene expression data. The authors calculated immune/stromal scores for all acute myeloid leukemia (AML) patients based on Estimation of STromal and Immune cells in Malignant Tumors using Expression data (ESTIMATE) algorithm, and they found that their calculated immune and stromal scores were associated with the subtype classification of AML patients. Next, the authors identified differentially expressed genes according to immune scores and stromal scores, and further found that key genes seem to have prognostic value for AML patients. Although we appreciate efforts of the authors for data analysis and collection, some evident mistakes were found out in this article. …
Literature
1.
go back to reference Yan H, Qu J, Cao W, Liu Y, Zheng G, Zhang E, Cai Z (2019) Identification of prognostic genes in the acute myeloid leukemia immune microenvironment based on TCGA data analysis. Cancer Immunol Immunother 68:1971–1978CrossRef Yan H, Qu J, Cao W, Liu Y, Zheng G, Zhang E, Cai Z (2019) Identification of prognostic genes in the acute myeloid leukemia immune microenvironment based on TCGA data analysis. Cancer Immunol Immunother 68:1971–1978CrossRef
2.
go back to reference Yoshihara K, Shahmoradgoli M, Martínez E et al (2013) Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun 4:2612CrossRef Yoshihara K, Shahmoradgoli M, Martínez E et al (2013) Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun 4:2612CrossRef
3.
go back to reference Shah N, Wang P, Wongvipat J et al (2017) Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer. Elife 6:e27861CrossRef Shah N, Wang P, Wongvipat J et al (2017) Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer. Elife 6:e27861CrossRef
Metadata
Title
ESTIMATE algorithm is not appropriate for inferring tumor purity and stromal and immune cell admixture in hematopoietic or stromal tumors
Authors
Qiang Liu
Yi Fang
Jing Wang
Publication date
01-06-2020
Publisher
Springer Berlin Heidelberg
Published in
Cancer Immunology, Immunotherapy / Issue 6/2020
Print ISSN: 0340-7004
Electronic ISSN: 1432-0851
DOI
https://doi.org/10.1007/s00262-020-02526-7

Other articles of this Issue 6/2020

Cancer Immunology, Immunotherapy 6/2020 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine